Company Active LTD

Company profile

Cardiology Devices Ltd

Home | Cardiology Devices Ltd

Cardiology Devices Ltd are a team of clinicians, engineers and academics developing a new device to treat advanced heart failure.

CRN
13702938
Founded
2021
Age
4

Overview

Legal name
CARDIOLOGY DEVICES LTD
Region
North West England
Registered address
CAMPUS TECHNOLOGY HUB, DARESBURY LABORATORY KECKWICK LANE
DARESBURY
WARRINGTON
ENGLAND
WA4 4AD
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

07 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

24 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

26 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0MTAwNjcxMWFkaXF6a2N4

Published 25 Oct 2024 11:19

26 Sep
2024

Accounts With Accounts Type Micro Entity

Accounts Analysed

AA | Transaction MzQzNzM2NTQ2MGFkaXF6a2N4

Published 26 Sep 2024 11:21

25 Oct
2021

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2024
Age at first award
1 years

Projects

2024 Launchpad Lead participant

Streamlining the Manufacturing for MyoCaid

1 May 2024 to 31 Dec 2024

Awarded
£88,043
Total cost £88,043

This project will advance the development of MyoCaid, an innovative new medical device to treat patients with advanced heart failure. Heart failure is the single biggest cause of death, and is responsible for approximately 60,000 deaths per year in the UK alone. Doctors have pills they can give to help patients with heart failure, but when heart failure b...

2022 Grant for R&D Lead participant

Developing a percutaneously permanent implantable left ventricular assist device to treat heart failure

1 Nov 2022 to 30 Apr 2023

Awarded
£48,750
Total cost £48,750

Cardiovascular disease is the most common cause of death in the UK. After a heart attack, the heart is weaker, and struggles to pump blood around the body. This causes less blood to get to the kidneys and brain and whilst patients can take medications to help, they cannot make the heart return to normal, and sadly approximately 60,000 people in the UK per...

Product types

Grant for R&D Launchpad